2018
DOI: 10.1136/bmjopen-2017-019027
|View full text |Cite
|
Sign up to set email alerts
|

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over­active bladder syndrome? An Australian cohort study

Abstract: ObjectivesTo investigate patterns of industry-sponsored educational events that focus on specific health conditions for which there are concerns about overdiagnosis and overtreatment.Design and settingThis retrospective cohort study examines publicly reported industry-sponsored events in Australia from October 2011 to September 2015 for three conditions potentially subject to overdiagnosis and overtreatment: depression, osteoporosis and overactive bladder. We used a database of transparency reports to identify… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
22
1
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 20 publications
0
22
1
2
Order By: Relevance
“…We observed that events began to occur before a drug was subsidised for a new indication, and that both prescribing and the number of events increased after the subsidy. A previous Australian study found that the pharmaceutical industry uses educational events to market products of low cost-effectiveness or uncertain safety in an effort to have them subsidised by the PBS 34. Our finding does not establish causality between pharmaceutical industry spending on events and increased prescribing.…”
Section: Discussioncontrasting
confidence: 71%
“…We observed that events began to occur before a drug was subsidised for a new indication, and that both prescribing and the number of events increased after the subsidy. A previous Australian study found that the pharmaceutical industry uses educational events to market products of low cost-effectiveness or uncertain safety in an effort to have them subsidised by the PBS 34. Our finding does not establish causality between pharmaceutical industry spending on events and increased prescribing.…”
Section: Discussioncontrasting
confidence: 71%
“…22 23 Pharmaceutical industry sponsored events have been shown to foster overdiagnosis and overtreatment of various conditions, including depression, osteoporosis and over active bladder syndrome. 24 Medical practitioners, particularly obstetricians and gynaecologists, were the primary recipients of payments and were present at the greatest number of educational events, reflecting their role in treatment and prescribing. We also reported frequent inclusion of nurses in pharmaceutical industry activities.…”
Section: Discussionmentioning
confidence: 99%
“… 22 23 Pharmaceutical industry sponsored events have been shown to foster overdiagnosis and overtreatment of various conditions, including depression, osteoporosis and over­active bladder syndrome. 24 …”
Section: Discussionmentioning
confidence: 99%
“…Our analysis of device company‐authored education is consistent with but also adds to what is known about pharmaceutical industry promotion. Analysis of pharmaceutical industry‐sponsored education suggests that these activities have promotional intent, which is furthered through education that aims to increase awareness of particular diseases for which the sponsor markets a product or to expand the patient populations for which a drug is indicated through promoting screening and diagnosis (Mintzes et al, 2018; Moynihan & Cassels, 2005). In the medical device industry, not only do companies seek to increase the use of devices through expanding indications, for example, in extending the focus from patients at risk for ventilator‐associated pneumonia to all hospitalised patients, but also need to increase the volume of product used.…”
Section: Discussionmentioning
confidence: 99%